Supplemental material
Expert Review of Vaccines
Volume 21, 2022 - Issue 3
Open access
4,895
Views
4
CrossRef citations to date
0
Altmetric
Review
Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices
Woo-Yun Sohna GSK, Rockville, MD, USACorrespondence[email protected]
https://orcid.org/0000-0002-4034-4735View further author information
, https://orcid.org/0000-0002-4034-4735View further author information
Halima Tahrata GSK, Rockville, MD, USAhttps://orcid.org/0000-0001-9846-6412View further author information
, Patricia Novyb GSK, Philadelphia, PA, USAhttps://orcid.org/0000-0003-0655-4672View further author information
& Rafik Bekkat-Berkania GSK, Rockville, MD, USAhttps://orcid.org/0000-0003-0683-6055View further author information
Pages 325-335
|
Received 19 Sep 2021, Accepted 20 Dec 2021, Published online: 23 Feb 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.